Mathieu-Jackson-elected-to-BOD-2024

Mathieu Jackson elected to WFH board of directors as Lay Member

The World Federation of Hemophilia (WFH) is very pleased to announce that Mathieu Jackson was elected to the WFH board of directors as a Lay Member at the Annual Meeting of the General Assembly at the WFH 2024 World Congress in Madrid, Spain, for a four-year term.

Also available in: Français Español

Mathieu Jackson has a Masters in Comparative Education and Fundamentals of Education from the University of Montreal, Canada. He is currently Lead of the School of Partnership at the Centre of Excellence on Partnerships with Patients and the Public (CEPPP) at the University of Montreal Hospital Research Centre (CRCHUM). He is a fellow of the 2017-2018 International AFFIRM Program on patient advocacy and leadership.

Jackson has hemophilia B and has been involved in the Canadian inherited bleeding disorders community for many years. He was president of the board of the Québec chapter of the Canadian Hemophilia Society from 2020 to 2024 and has been involved in different ways with the Canadian Hemophilia Society, both on the board and on multiple committees. Among other things, Mathieu Jackson facilitated the integration of patients-as-experts in the elaboration of the WFH Guidelines for the Management of Hemophilia, 3rd edition and is a faculty member and mentor in the WFH PACT Advocacy Academy program. 

Mathieu Jackson’s invaluable experience will be a great asset to the WFH as a Lay Member. Please join us in welcoming him to the WFH Board of Directors.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.